NPI: 1699125526 · KILMARNOCK, VA 22482 · Critical Access Hospital · NPI assigned 06/22/2016
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 06/22/2016 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,332 | $95K |
| 2019 | 12,535 | $483K |
| 2020 | 10,954 | $572K |
| 2021 | 16,545 | $746K |
| 2022 | 22,459 | $1.14M |
| 2023 | 21,068 | $1.47M |
| 2024 | 18,361 | $1.50M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 8,686 | 7,681 | $2.04M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,486 | 3,841 | $1.03M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,322 | 2,766 | $787K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,358 | 1,052 | $458K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,874 | 1,650 | $382K |
| 70450 | Computed tomography, head or brain; without contrast material | 836 | 729 | $208K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 573 | 510 | $205K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,429 | 969 | $156K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 974 | 908 | $130K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 181 | 114 | $77K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,145 | 1,082 | $69K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,353 | 1,260 | $58K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 256 | 226 | $57K |
| 71046 | Radiologic examination, chest; 2 views | 2,100 | 1,883 | $42K |
| 80053 | Comprehensive metabolic panel | 6,692 | 5,194 | $31K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 851 | 804 | $31K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 54 | 51 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 353 | 333 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 245 | 221 | $22K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 375 | 282 | $18K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 92 | 74 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 421 | 404 | $15K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 298 | 85 | $13K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,200 | 2,006 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,205 | 2,051 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,986 | 2,310 | $9K |
| 85018 | 1,074 | 1,054 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,686 | 5,780 | $6K |
| 87040 | 820 | 371 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,128 | 2,577 | $5K |
| 87634 | 176 | 166 | $4K | |
| 36415 | Collection of venous blood by venipuncture | 9,220 | 6,611 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,917 | 1,477 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,434 | 2,624 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | 847 | 585 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,294 | 896 | $3K |
| 71045 | Radiologic examination, chest; single view | 2,306 | 1,902 | $2K |
| 84484 | 2,917 | 1,911 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 330 | 304 | $2K |
| 73030 | 43 | 39 | $2K | |
| 81001 | 4,152 | 3,493 | $1K | |
| 83880 | 137 | 109 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 314 | 303 | $1K |
| 81003 | 423 | 388 | $890.37 | |
| 73562 | 91 | 81 | $860.47 | |
| 83605 | 1,138 | 829 | $841.55 | |
| 81025 | 1,694 | 1,507 | $778.51 | |
| 83735 | 1,987 | 1,495 | $778.40 | |
| 73630 | 43 | 40 | $638.66 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 983 | 478 | $619.15 |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,503 | 1,888 | $551.42 |
| 82962 | 1,132 | 520 | $506.56 | |
| 73610 | 27 | 25 | $395.32 | |
| J3490 | Unclassified drugs | 1,078 | 585 | $381.83 |
| 87807 | 98 | 93 | $370.63 | |
| 85610 | 538 | 432 | $326.62 | |
| 82553 | 59 | 42 | $262.96 | |
| 84443 | Thyroid stimulating hormone (TSH) | 47 | 38 | $205.43 |
| 81002 | 60 | 57 | $203.33 | |
| 85379 | 76 | 65 | $180.70 | |
| 87070 | 1,145 | 1,059 | $179.33 | |
| 83690 | 1,603 | 1,321 | $153.97 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 471 | 391 | $140.57 |
| J2060 | Injection, lorazepam, 2 mg | 17 | 12 | $113.51 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,129 | 939 | $91.01 |
| 80306 | 63 | 54 | $58.91 | |
| 82550 | 126 | 87 | $37.73 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 464 | 331 | $36.81 |
| J7050 | Infusion, normal saline solution, 250 cc | 475 | 270 | $34.11 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 213 | 174 | $24.14 |
| 82077 | 102 | 85 | $16.64 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 75 | 53 | $7.21 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,223 | 1,082 | $6.91 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 62 | 37 | $6.34 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 33 | 24 | $5.52 |
| 96376 | 444 | 281 | $5.39 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 125 | 62 | $4.13 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 36 | 30 | $0.49 |
| 87186 | 16 | 13 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 14 | 13 | $0.00 |
| 94762 | 77 | 68 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 45 | 41 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 98 | 92 | $0.00 |
| 87147 | 30 | 29 | $0.00 | |
| 94760 | 17 | 12 | $0.00 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18 | 12 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 16 | 13 | $0.00 |